A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH

Native Study Group, Sven M. Francque, Pierre Bedossa, Vlad Ratziu, Quentin M. Anstee, Elisabetta Bugianesi, Arun J. Sanyal, Rohit Loomba, Stephen A. Harrison, Rozalina Balabanska, Lyudmila Mateva, Nicolas Lanthier, Naim Alkhouri, Christophe Moreno, Jörn M. Schattenberg, Diana Stefanova-Petrova, Luisa Vonghia, Régine Rouzier, Maeva Guillaume, Alexander HodgeManuel Romero-Gómez, Philippe Huot-Marchand, Martine Baudin, Marie Paule Richard, Jean Louis Abitbol, Pierre Broqua, Jean Louis Junien, Manal F. Abdelmalek

Research output: Contribution to journal › Article › peer-review

472 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH'. Together they form a unique fingerprint.

Medicine and Dentistry